Haleon Announces $87-Million Investment in Shanghai Facility to Boost Asia Growth.

Haleon PLC is investing £65 million (around $87.2 million) in a new oral health manufacturing plant in Shanghai, reinforcing its focus on key growth markets such as China and India.

The company aims to deepen its product portfolio, with bolt-on mergers and acquisitions remaining a strategic priority, CEO Brian McNamara said in a Bloomberg TV interview on Wednesday in Shanghai.

E-commerce plays a crucial role in Haleon’s China operations, accounting for roughly 40% of its business in the country. McNamara highlighted that online channels will be central to the next phase of the company’s expansion in China, its second-largest market globally.